164 related articles for article (PubMed ID: 11451666)
1. RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein.
Razinkov V; Gazumyan A; Nikitenko A; Ellestad G; Krishnamurthy G
Chem Biol; 2001 Jul; 8(7):645-59. PubMed ID: 11451666
[TBL] [Abstract][Full Text] [Related]
2. RSV entry inhibitors block F-protein mediated fusion with model membranes.
Razinkov V; Huntley C; Ellestad G; Krishnamurthy G
Antiviral Res; 2002 Jul; 55(1):189-200. PubMed ID: 12076763
[TBL] [Abstract][Full Text] [Related]
3. The discovery of RFI-641 as a potent and selective inhibitor of the respiratory syncytial virus.
Nikitenko AA; Raifeld YE; Wang TZ
Bioorg Med Chem Lett; 2001 Apr; 11(8):1041-4. PubMed ID: 11327584
[TBL] [Abstract][Full Text] [Related]
4. RFI-641, a potent respiratory syncytial virus inhibitor.
Huntley CC; Weiss WJ; Gazumyan A; Buklan A; Feld B; Hu W; Jones TR; Murphy T; Nikitenko AA; O'Hara B; Prince G; Quartuccio S; Raifeld YE; Wyde P; O'Connell JF
Antimicrob Agents Chemother; 2002 Mar; 46(3):841-7. PubMed ID: 11850270
[TBL] [Abstract][Full Text] [Related]
5. Inhalation efficacy of RFI-641 in an African green monkey model of RSV infection.
Weiss WJ; Murphy T; Lynch ME; Frye J; Buklan A; Gray B; Lenoy E; Mitelman S; O'Connell J; Quartuccio S; Huntley C
J Med Primatol; 2003 Apr; 32(2):82-8. PubMed ID: 12823630
[TBL] [Abstract][Full Text] [Related]
6. Two novel fusion inhibitors of human respiratory syncytial virus.
Lundin A; Bergström T; Bendrioua L; Kann N; Adamiak B; Trybala E
Antiviral Res; 2010 Dec; 88(3):317-24. PubMed ID: 20965215
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay.
Morton CJ; Cameron R; Lawrence LJ; Lin B; Lowe M; Luttick A; Mason A; McKimm-Breschkin J; Parker MW; Ryan J; Smout M; Sullivan J; Tucker SP; Young PR
Virology; 2003 Jul; 311(2):275-88. PubMed ID: 12842618
[TBL] [Abstract][Full Text] [Related]
8. Furin cleavage of the respiratory syncytial virus fusion protein is not a requirement for its transport to the surface of virus-infected cells.
Sugrue RJ; Brown C; Brown G; Aitken J; McL Rixon HW
J Gen Virol; 2001 Jun; 82(Pt 6):1375-1386. PubMed ID: 11369882
[TBL] [Abstract][Full Text] [Related]
9. Cell fusion assay by expression of respiratory syncytial virus (RSV) fusion protein to analyze the mutation of palivizumab-resistant strains.
Yasui Y; Yamaji Y; Sawada A; Ito T; Nakayama T
J Virol Methods; 2016 May; 231():48-55. PubMed ID: 26794681
[TBL] [Abstract][Full Text] [Related]
10. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
Perron M; Stray K; Kinkade A; Theodore D; Lee G; Eisenberg E; Sangi M; Gilbert BE; Jordan R; Piedra PA; Toms GL; Mackman R; Cihlar T
Antimicrob Agents Chemother; 2015 Dec; 60(3):1264-73. PubMed ID: 26666922
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of respiratory syncytial virus fusion inhibitors.
Battles MB; Langedijk JP; Furmanova-Hollenstein P; Chaiwatpongsakorn S; Costello HM; Kwanten L; Vranckx L; Vink P; Jaensch S; Jonckers TH; Koul A; Arnoult E; Peeples ME; Roymans D; McLellan JS
Nat Chem Biol; 2016 Feb; 12(2):87-93. PubMed ID: 26641933
[TBL] [Abstract][Full Text] [Related]
12. RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.
Budge PJ; Li Y; Beeler JA; Graham BS
J Virol; 2004 May; 78(10):5015-22. PubMed ID: 15113882
[TBL] [Abstract][Full Text] [Related]
13. Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein.
Meng J; Hotard AL; Currier MG; Lee S; Stobart CC; Moore ML
J Virol; 2016 Jan; 90(1):245-53. PubMed ID: 26468535
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity.
Leemans A; Boeren M; Van der Gucht W; Martinet W; Caljon G; Maes L; Cos P; Delputte P
Virus Res; 2019 Jun; 266():58-68. PubMed ID: 31004621
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane.
Tang W; Li M; Liu Y; Liang N; Yang Z; Zhao Y; Wu S; Lu S; Li Y; Liu F
FASEB J; 2019 Mar; 33(3):4287-4299. PubMed ID: 30571312
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a persistent respiratory syncytial virus showing a low-fusogenic activity associated to an impaired F protein.
Sarmiento RE; Arias CF; Méndez E; Gómez B
Virus Res; 2009 Jan; 139(1):39-47. PubMed ID: 19014983
[TBL] [Abstract][Full Text] [Related]
17. Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after
Phan SI; Adam CM; Chen Z; Citron M; Liang X; Espeseth AS; Wang D; He B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747497
[TBL] [Abstract][Full Text] [Related]
18. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028).
Sudo K; Konno K; Watanabe W; Shigeta S; Yokota T
Microbiol Immunol; 2001; 45(7):531-7. PubMed ID: 11529559
[TBL] [Abstract][Full Text] [Related]
20. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate.
Feldman SA; Audet S; Beeler JA
J Virol; 2000 Jul; 74(14):6442-7. PubMed ID: 10864656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
